Bovens AA - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Hobit and Blimp-1 regulate T_RM abundance after LCMV infection by suppressing tissue exit pathways of T_RM precursors.

Parga-Vidal L, Taggenbrock RLRE, Beumer-Chuwonpad A, Aglmous H, Kragten NAM, Behr FM, Bovens AA, van Lier RAW, Stark R, van Gisbergen KPJM. Parga-Vidal L, et al. Among authors: bovens aa. Eur J Immunol. 2022 Jul;52(7):1095-1111. doi: 10.1002/eji.202149665. Epub 2022 Apr 15. Eur J Immunol. 2022. PMID: 35389518 Free PMC article.

Murine iNKT cells are depleted by liver damage via activation of P2RX7.

Bovens AA, Wesselink TH, Behr FM, Kragten NAM, van Lier RAW, van Gisbergen KPJM, Stark R. Bovens AA, et al. Eur J Immunol. 2020 Oct;50(10):1515-1524. doi: 10.1002/eji.201948509. Epub 2020 May 27. Eur J Immunol. 2020. PMID: 32390174 Free article.

CD4⁺ T cell help creates memory CD8⁺ T cells with innate and help-independent recall capacities.

Ahrends T, Busselaar J, Severson TM, Bąbała N, de Vries E, Bovens A, Wessels L, van Leeuwen F, Borst J. Ahrends T, et al. Nat Commun. 2019 Dec 4;10(1):5531. doi: 10.1038/s41467-019-13438-1. Nat Commun. 2019. PMID: 31797935 Free PMC article.

Subcellular Localization of Antigen in Keratinocytes Dictates Delivery of CD4⁺ T-cell Help for the CTL Response upon Therapeutic DNA Vaccination into the Skin.

Bąbała N, Bovens A, de Vries E, Iglesias-Guimarais V, Ahrends T, Krummel MF, Borst J, Bins AD. Bąbała N, et al. Cancer Immunol Res. 2018 Jul;6(7):835-847. doi: 10.1158/2326-6066.CIR-17-0408. Epub 2018 May 15. Cancer Immunol Res. 2018. PMID: 29764836

CD4⁺ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness.

Ahrends T, Spanjaard A, Pilzecker B, Bąbała N, Bovens A, Xiao Y, Jacobs H, Borst J. Ahrends T, et al. Immunity. 2017 Nov 21;47(5):848-861.e5. doi: 10.1016/j.immuni.2017.10.009. Epub 2017 Nov 7. Immunity. 2017. PMID: 29126798 Free article.

Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy.

Guelen L, Fischmann TO, Wong J, Mauze S, Guadagnoli M, Bąbała N, Wagenaars J, Juan V, Rosen D, Prosise W, Habraken M, Lodewijks I, Gu D, Stammen-Vogelzangs J, Yu Y, Baker J, Lutje Hulsik D, Driessen-Engels L, Malashock D, Kreijtz J, Bertens A, de Vries E, Bovens A, Bramer A, Zhang Y, Wnek R, Troth S, Chartash E, Dobrenkov K, Sadekova S, van Elsas A, Cheung JK, Fayadat-Dilman L, Borst J, Beebe AM, Van Eenennaam H. Guelen L, et al. J Immunother Cancer. 2022 Sep;10(9):e005049. doi: 10.1136/jitc-2022-005049. J Immunother Cancer. 2022. PMID: 36100308 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6 results

Search Page

Filters